These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2419915)

  • 1. Hepatic glutathione S-transferase activity in mice: effects of Avy/-genotype, obesity, lindane treatment, and sex.
    Wolff GL; Suber RL
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):535-41. PubMed ID: 2419915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenic responses to lindane in mice: potentiation by a dominant mutation.
    Wolff GL; Roberts DW; Morrissey RL; Greenman DL; Allen RR; Campbell WL; Bergman H; Nesnow S; Frith CH
    Carcinogenesis; 1987 Dec; 8(12):1889-97. PubMed ID: 2445499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age and obesity on the metabolism of lindane by black a/a, yellow Avy/a, and pseudoagouti Avy/a phenotypes of (YS x VY) F1 hybrid mice.
    Chadwick RW; Copeland MF; Wolff GL; Cooke N; Whitehouse DA; Mole ML
    J Toxicol Environ Health; 1985; 16(6):771-96. PubMed ID: 2419580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase activity and isoenzyme concentrations in obese Avy/a and lean a/a mice.
    York JL; Wolff GL
    Proc Soc Exp Biol Med; 1994 Feb; 205(2):186-9. PubMed ID: 8108470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal determination of obesity, tumor susceptibility, and coat color pattern in viable yellow (Avy/a) mice. The yellow mouse syndrome.
    Wolff GL; Roberts DW; Galbraith DB
    J Hered; 1986; 77(3):151-8. PubMed ID: 3734404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple levels of response in carcinogenicity bioassays: regulational variation among viable yellow (Avy/-) mice.
    Wolff GL
    J Exp Anim Sci; 1993 Sep; 35(5-6):221-31. PubMed ID: 8218437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturation of lindane metabolism in chronically treated (YS x VY) F1 hybrid mice.
    Chadwick RW; Copeland MF; Wolff GL; Stead AG; Mole ML; Whitehouse DA
    J Toxicol Environ Health; 1987; 20(4):411-34. PubMed ID: 2435921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the mottled yellow and pseudoagouti phenotypes on immunocompetence in Avy/a mice.
    Roberts DW; Wolff GL; Campbell WL
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2152-6. PubMed ID: 6609359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response effects of ectopic agouti protein on iron overload and age-associated aspects of the Avy/a obese mouse phenome.
    Wolff GL; Whittaker P
    Peptides; 2005 Oct; 26(10):1697-711. PubMed ID: 15982784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of glucose tolerance in yellow (Avy/A) (BALB/c X VY) F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands.
    Frigeri LG; Wolff GL; Robel G
    Endocrinology; 1983 Dec; 113(6):2097-105. PubMed ID: 6357766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified response to phenobarbital promotion of hepatotumorigenesis in obese yellow Avy/A (C3H x VY) F-1 hybrid mice.
    Wolff GL; Morrissey RL; Chen JJ
    Carcinogenesis; 1986 Nov; 7(11):1895-8. PubMed ID: 3769139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid mice.
    Wolff GL; Leakey JE; Bazare JJ; Harmon JR; Webb PJ; Law MG
    Carcinogenesis; 1991 May; 12(5):911-5. PubMed ID: 1674234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of maternal phenotype on metabolic differentiation of agouti locus mutants in the mouse.
    Wolff GL
    Genetics; 1978 Mar; 88(3):529-39. PubMed ID: 640377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutations.
    Wolff GL; Galbraith DB; Domon OE; Row JM
    J Hered; 1978; 69(5):295-8. PubMed ID: 744871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice.
    Roe AL; Howard G; Blouin R; Snawder JE
    Int J Obes Relat Metab Disord; 1999 Jan; 23(1):48-53. PubMed ID: 10094576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice.
    Wolff GL; Kodell RL; Moore SR; Cooney CA
    FASEB J; 1998 Aug; 12(11):949-57. PubMed ID: 9707167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone-induced hyperglycemia in obese Avy/a (viable yellow) female mice entails preferential induction of a hepatic estrogen sulfotransferase.
    Gill AM; Leiter EH; Powell JG; Chapman HD; Yen TT
    Diabetes; 1994 Aug; 43(8):999-1004. PubMed ID: 8039608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lindane treatment on drug metabolizing enzymes and liver weight of CF1 mice in which it evoked hepatomas and in non-susceptible rodents.
    Oesch F; Friedberg T; Herbst M; Paul W; Wilhelm N; Bentley P
    Chem Biol Interact; 1982 May; 40(1):1-14. PubMed ID: 6176340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity.
    Frigeri LG; Wolff GL; Teguh C
    Int J Obes; 1988; 12(4):305-20. PubMed ID: 3058616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions.
    Kaput J; Klein KG; Reyes EJ; Kibbe WA; Cooney CA; Jovanovic B; Visek WJ; Wolff GL
    Physiol Genomics; 2004 Aug; 18(3):316-24. PubMed ID: 15306695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.